Allergy Diagnostics & Therapeutics Market Size, Sector / Industry Report & Analysis, 2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Allergy Diagnostics & Therapeutics Market


The global Allergy Diagnostics & Therapeutics market size is projected to reach US$ 52.27 billion by 2026, from US$ 36.23 billion in 2020, at a CAGR of 6.3% during 2021-2026. Increasing incidences of allergic diseases coupled with high demand for in vitro diagnostic blood tests is projected to drive the industry growth in the coming years.
According to the estimates published by the World Health Organization (WHO), around 40 million cases of inhaled allergies were reported in 2012 in U.S. and the number is increasing contributing toward the growth of this market. In addition, factors, such as changing lifestyle, increasing levels of indoor and outdoor pollution, poor dietary habits, and rapid urbanization across the globe are estimated to result in increased incidences of allergic conditions.

This, in turn, is projected to help augment the market growth over the next few years. The introduction of technologically advanced diagnostic and therapeutic products, which offer highly sensitive and accurate results, is also expected to have a positive impact on the market growth of the global market over the forecast period.
Inhaled allergen type segment accounted for the largest market share in 2018 and is projected to maintain its dominance over the forecast years. This growth can be attributed to the increasing cases of respiratory allergies. According to the statistics published in 2012 by American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide.

Market Segmentation, Outlook & Viewpoint: Global Allergy Diagnostics & Therapeutics Market

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Instruments
  
Consumables
  
Services

Allergen Type Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Food
  
Inhaled
  
Drug
  
Other
  
End Use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)
  
Diagnostic Laboratories
  
Hospitals
  
Academic Research Institutes

Test Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

In vivo Test

  
Skin Prick Test
  
Intradermal Test
  
Patch Test

In vitro Test

Drug Class Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Antihistamines
  
Decongestants
  
Corticosteroids
  
Mast Cell Stabilizers
  
Leukotriene Inhibitors
  
Nasal Anticholinergics
  
Immunomodulators
  
Autoinjectable Epinephrine
  
Immunotherapy

Key Players, Recent Developments & Regional Insights: Global Allergy Diagnostics & Therapeutics Market

Product segment include instruments, consumables, and services. Consumables led the overall market in 2018 as they are indispensable component in allergy detection. Technological advancements, such as allergen microarray kits, which are more sensitive and offer individualized patient profiling and monitoring, are projected to drive the segment further. In addition, advent of products, such as MeDALL allergen-chip associated with enhanced sensitivity specificity, and faster diagnosis is projected to support the market expansion.
Allergen Type Insights

Based on allergen type, the market is categorized into food, inhaled, drug, and others. Inhaled allergen led the global allergy diagnostics and therapeutics market in 2018 due to increased incidences of respiratory allergies and asthma across the globe. The segment is projected to expand further at the fastest CAGR owing to high demand for allergy testing and introduction of specific allergen for the detection of allergy.

Drug allergies segment is also expected to register a strong CAGR of 11.3% from 2019 to2025. Food allergies was the second-largest segment, in terms of revenue share, and is projected to continue the trend throughout the forecast years. Children are more susceptible to these types of allergic diseases. According to the estimates published by the U.S. National Institute of Health (NIH), prevalence of food allergies among children is double than that of in adults.

Drug Class Insights

Antihistamines accounted for the largest market share in 2018 on account of their associated benefits and wide applications in the treatment of allergy diseases. According to the estimates published by the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects approximately 10.0 to 30.0% of the global population, thereby contributing toward the adoption of allergy therapeutics. Major causes of allergic conditions include factors, such as changing lifestyle, poor dietary habits, and rising pollution levels.

The introduction of therapeutically advanced drugs, such as monoclonal antibodies possessing higher efficacy than conventional drugs, is expected to boost the market over the forecast period. Immunotherapy is expected to be the fastest-growing segment with a CAGR of 7.1% from 2019 to 2025 owing to increasing demand for sublingual vaccines, extensive drug pipeline, ongoing clinical trials of monoclonal antibodies for the treatment of allergic disorders, and growing awareness among patients.
End Use Insights

Based on end use, the market has been divide into academic research institutes, hospitals, and diagnostic laboratories. Diagnostic laboratories held the largest market share of 49.8% in 2018 due to extensive utilization of immunoassay tests in allergy diagnosis.

The advancements in screening techniques enabling accurate disease diagnosis and stratification for appropriate treatment is expected to drive the segment further. Hospitals is expected to be the fastest-growing segment due to supportive government funding and rising healthcare expenditure.

Regional Insights
North America led the global market, in terms of revenue, in 2018 on account of high incidence of respiratory allergic disorders along with rising awareness levels about allergy diagnostics and adoption of in vitro blood tests. Europe is expected to be the second-largest regional market due to the presence of developed pharmaceutical industry and increasing demand for therapeutics. Growing geriatric population and rising incidences of allergic conditions are also contributing to the regions growth. Asia Pacific is expected to be the fastest-growing regional market registering a CAGR of 13.2% from 2019 to 2025 due to rapidly improvising healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools.
Allergy Diagnostics And Therapeutics Market Share Insights

Some of the key companies in the global market include bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, and Alcon Laboratories. The market is highly competitive and companies are actively involved in new product launches, strategic collaborations, acquisitions, and technological advancements to gain maximum market share.

For example, in October 2017, Stallergenes Greer acquired Medic Savoure Ltd., thereby strengthening its presence in Canadian allergy immunotherapy market. In addition, in July 2016, Novartis AG received FDA approval for use of its product, Xolair, in the treatment of pediatric allergic asthma, which helped expand its product portfolio.

Key Insights Covered: Global Allergy Diagnostics & Therapeutics Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Allergy Diagnostics & Therapeutics industry.
2. Global major manufacturers" operating situation (sales, revenue, growth rate and gross margin) of Allergy Diagnostics & Therapeutics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Allergy Diagnostics & Therapeutics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Allergy Diagnostics & Therapeutics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Allergy Diagnostics & Therapeutics industry.

Research Methodology: Global Allergy Diagnostics & Therapeutics Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other